PQQ

Pyrroloquinoline quinone (PQQ) is being investigated for several clinical applications, though research remains in early stages for most conditions.

Neurological and Cognitive Applications

PQQ has been studied for cognitive enhancement and neuroprotection. A completed Phase 3 trial (NCT06431113) evaluated a fixed combination of citicoline, homotaurine, and PQQ on pattern electroretinogram responses in glaucoma patients, though specific results are not provided in the available evidence. Another completed study (NCT05910047) examined supplemental hydrogen plus PQQ for mitochondrial biomarkers and brain function in elderly individuals with mild cognitive impairment.

Preclinical research suggests PQQ may modulate morphine tolerance and dependence through N-methyl-D-aspartate receptor signaling pathways and by reducing oxidative neuroinflammation, though this has only been demonstrated in mouse models.

Metabolic and Cardiovascular Conditions

Research indicates potential applications for diabetes-related complications. One preclinical study found that PQQ mitigated type 2 diabetes-induced cardiac injury through mitochondrial quality control mechanisms and inhibition of inflammatory pathways, specifically NLRP3-dependent pyroptosis. However, this evidence comes from laboratory studies rather than human trials.

Longevity and Anti-Aging

PQQ is being investigated as part of longevity-focused interventions. Research has examined its effects on redox homeostasis and longevity-associated gene expression in cellular models. A completed study (NCT07571629) evaluated a PQQ-containing supplement on skin aging parameters over 56 days, though results are not available in the provided evidence.

Reproductive Health

A withdrawn early-phase trial (NCT06245083) was planned to evaluate PQQ for improving pregnancy outcomes in obese women, but this study did not proceed to completion.

Current Evidence Limitations

The clinical evidence for PQQ remains limited. While several trials have been completed, specific results and efficacy data are not available in the provided evidence. Much of the mechanistic understanding comes from preclinical studies in animal models and cell cultures. More robust human clinical trial data is needed to establish PQQ's therapeutic efficacy for any specific medical condition.

This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before using PQQ or any supplement for medical purposes.